Clinical Trials
5
Trial Phases
2 Phases
Drug Approvals
5
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)โข Click on a phase to view related trials
Treatment of Lung Injury From COVID-19 Infection With Intravenous Sodium Nitrite
- Conditions
- COVID-19Acute Respiratory Distress SyndromeAcute Respiratory Failure
- Interventions
- Drug: Normal Saline
- First Posted Date
- 2020-05-26
- Last Posted Date
- 2020-09-16
- Lead Sponsor
- Hope Pharmaceuticals
- Registration Number
- NCT04401527
- Locations
- ๐บ๐ธ
Participating Research Facility, Fort Worth, Texas, United States
Observational Follow-up to ST-001 Calciphylaxis Pain Treatment With Intravenous Sodium Thiosulfate
- Conditions
- Calciphylaxis
- First Posted Date
- 2017-10-24
- Last Posted Date
- 2018-11-20
- Lead Sponsor
- Hope Pharmaceuticals
- Target Recruit Count
- 5
- Registration Number
- NCT03319914
- Locations
- ๐บ๐ธ
Massachusetts General Hospital, Boston, Massachusetts, United States
๐บ๐ธVeterans Administration Medical Center, Albany, New York, United States
๐บ๐ธCleveland Clinic, Cleveland, Ohio, United States
A Phase 3 Clinical Trial of Intravenous Sodium Thiosulfate in Acute Calciphylaxis Patients
- Conditions
- Calciphylaxis
- Interventions
- Drug: Placebo-Normal Saline
- First Posted Date
- 2017-05-12
- Last Posted Date
- 2020-05-19
- Lead Sponsor
- Hope Pharmaceuticals
- Target Recruit Count
- 29
- Registration Number
- NCT03150420
- Locations
- ๐บ๐ธ
Mayo Clinic, Jacksonville, Florida, United States
๐บ๐ธNorthwestern University Hospital, Chicago, Illinois, United States
๐บ๐ธLoyola University Medical Center, Maywood, Illinois, United States
Intravenous Nitrite Infusion for Reversal of Cerebral Vasospasm After Subarachnoid Hemorrhage
- First Posted Date
- 2014-06-27
- Last Posted Date
- 2018-03-30
- Lead Sponsor
- Hope Pharmaceuticals
- Target Recruit Count
- 6
- Registration Number
- NCT02176837
- Locations
- ๐บ๐ธ
University of Virginia Medical Center, Charlottesville, Virginia, United States
Safety and Pharmacokinetic Evaluation of Nitrite for Prevention of Cerebral Vasospasm
- First Posted Date
- 2009-04-01
- Last Posted Date
- 2020-05-21
- Lead Sponsor
- Hope Pharmaceuticals
- Target Recruit Count
- 19
- Registration Number
- NCT00873015
- Locations
- ๐บ๐ธ
University of Virginia Health System Medical Center, Charlottesville, Virginia, United States